Chartwell Investment Partners’s Axcelis ACLS Stock Holding History

Chartwell Investment Partners’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,676	Closed	-$437K	–	420
2023 Q3	$437K	Buy	+2,676	New	+$471K	0.02%	396

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Chartwell Investment Partners's ACLS Position: Q4 2023 in Review

Chartwell Investment Partners sold out of Axcelis (ACLS) in Q4 2023, closing a stake of 2,676 shares — an estimated $437K sold.

Chartwell Investment Partners first reported a position in ACLS in Q3 2023 and held it in 1 quarter. The position peaked at $437K in Q3 2023. 421 funds tracked by Wall St. Rank hold ACLS as of Q4 2023.

Chartwell Investment Partners reported no remaining Axcelis position as of Q4 2023 after selling out during the quarter.
Chartwell Investment Partners sold 2,676 Axcelis shares in Q4 2023, an estimated $437K.
Chartwell Investment Partners first reported a position in Axcelis in Q3 2023 and held it in 1 quarter.
Chartwell Investment Partners's Axcelis position peaked at $437K in Q3 2023.
421 funds tracked by Wall St. Rank held Axcelis as of Q4 2023.

Based on Chartwell Investment Partners's 13F filing for Q4 2023, filed 15 Feb 2024.